Management and treatment of deep vein thrombosis in special populations
Authors:
- 25 July 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 11 (9) , 685-695
Abstract
Introduction: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most frequent cardiovascular disease besides myocardial infarction and stroke. Because DVT may cause life-threatening conditions, treatment should be started as soon as possible. This comprises certain challenges in special populations. Areas covered: In cancer-associated VTE, current treatment is different from non-cancer VTE due to disease-related interventions and higher bleeding risks. In the treatment of patients with extensive DVT, the role of catheter-directed thrombolysis has been investigated in two randomized trials, but results do not yield a recommendation for standard thrombolysis. The diagnosis of suspected recurrent DVT is especially challenging in case of ipsilateral DVT. Treatment strategies in recurrent DVT are dependent on the case and on particular risk factors. Also discussed is the therapy for DVT in pregnant women, which is more complex as a result of anticoagulants crossing the placenta. Expert commentary: DVT treatment in special populations poses special challenges due to high thrombotic and bleeding risk. This will be discussed in more detail in this review.Keywords
Funding Information
- not funded
This publication has 69 references indexed in Scilit:
- Treatment and Prevention of Heparin-Induced ThrombocytopeniaChest, 2012
- VTE, Thrombophilia, Antithrombotic Therapy, and PregnancyChest, 2012
- EULAR recommendations for the management of Behçet diseaseAnnals of the Rheumatic Diseases, 2008
- The post‐thrombotic syndrome: progress and pitfallsBritish Journal of Haematology, 2006
- Vitamin K antagonists and pregnancy outcomeThrombosis and Haemostasis, 2006
- Thrombosis during pregnancy and the postpartum periodAmerican Journal of Obstetrics and Gynecology, 2005
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002
- Teratogen update: Fetal effects after in utero exposure to coumarins Overview of cases, follow‐up findings, and pathogenesisTeratology, 2002
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- The warfarin embryopathy: A rat model showing maxillonasal hypoplasia and other skeletal disturbancesTeratology, 1992